HighTower Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,000
Closed -$12.6K 3869
2025
Q2
$12.6K Buy
+4,000
New +$534K ﹤0.01% 3634
2024
Q4
Sell
-1,000
Closed -$1 3851
2024
Q3
$1 Buy
+1,000
New +$148K ﹤0.01% 3728
2018
Q1
Sell
-1,000
Closed -$8K 2212
2017
Q4
$8K Buy
+1,000
New +$136K ﹤0.01% 2190
2016
Q2
Sell
-800
Closed -$3.92M 1810
2016
Q1
$3.92M Buy
+800
New +$102K 0.01% 470

Other funds holding CLX

HighTower Advisors's CLX Position: Q1 2026 in Review

HighTower Advisors increased its Clorox (CLX) stake by 8.8% in Q1 2026, buying an estimated $516K and bringing the position to 56,501 shares worth $5.86M. The position accounts for 0.01% of the portfolio, ranked #1118.

HighTower Advisors first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $64.2M in Q4 2024. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • HighTower Advisors held 56,501 shares of Clorox worth $5.86M as of Q1 2026.
  • HighTower Advisors bought 4,553 Clorox shares in Q1 2026, an estimated $516K.
  • Clorox made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #1118 holding.
  • HighTower Advisors first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
  • HighTower Advisors's Clorox position peaked at $64.2M in Q4 2024.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.